This section captures critical facility identification and real-time environmental monitoring data at the moment of contamination detection. All fields marked mandatory must be completed to ensure traceability and regulatory compliance.
Facility Registration Number
Cleanroom/Surgical Suite Unique Identifier
Cleanroom Classification Standard
ISO 14644-1 Class 5
ISO 14644-1 Class 6
ISO 14644-1 Class 7
ISO 14644-1 Class 8
US FED STD 209E Class 100
US FED STD 209E Class 1,000
US FED STD 209E Class 10,000
EU GMP Grade A
EU GMP Grade B
EU GMP Grade C
EU GMP Grade D
Specific Location Within Facility
Exact Timestamp of Initial Positive Contamination Detection
Timestamp of Last Successful Certification/Validation
Days Since Last Successful Certification
Was this detection triggered by an automated Environmental Monitoring System (EMS) alarm?
EMS System Manufacturer & Model
Describe the manual detection method and circumstances
Number of Active Environmental Sampling Points in the Suite
Number of Sampling Points Showing Elevated Readings
Environmental Telematics Snapshot at Detection Moment
Parameter | Current Value | Unit of Measurement | Acceptable Range | Deviation Severity (1=Normal, 5=Critical) | ||
|---|---|---|---|---|---|---|
A | B | C | D | E | ||
1 | Air Pressure Differential | 0.02 | inches water column | 0.03-0.05 | ||
2 | Temperature | 22.5 | °C | 20-24 | ||
3 | Relative Humidity | 58 | % | 45-60 | ||
4 | Air Changes Per Hour (ACH) | 18 | changes/hour | 20-25 | ||
5 | ||||||
6 | ||||||
7 | ||||||
8 | ||||||
9 | ||||||
10 |
Personnel Present in Suite at Time of Detection (select all applicable roles)
Sterile Compounding Pharmacist
Certified Pharmacy Technician
Surgical Team Member
Anesthesiologist
Circulating Nurse
Scrub Nurse
Facility Engineer
Environmental Services Staff
Quality Assurance Auditor
No Personnel Present
Other
Was any sterile compounding or surgical procedure actively in progress?
Provide detailed description of the procedure, stage, and potential impact on product/patient safety
Are there any current maintenance activities or construction projects in adjacent areas?
Describe the nature, location, and proximity of the activity
This section documents comprehensive particulate and microbiological contamination data, comparing current readings against established baselines and regulatory limits. Complete variance calculations and identify contamination characteristics.
Airborne Particle Count Analysis by ISO 14644-1 Standards
Particle Size (µm) | Baseline Count (particles/m³) | Current Count (particles/m³) | Regulatory Limit (particles/m³) | Variance % from Baseline | Exceedance Factor vs Limit | ||
|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | ||
1 | 0.5 | 3520 | 12500 | 3520 | 255.113636364 | 3.551136364 | |
2 | 1 | 832 | 3200 | 832 | 284.615384615 | 3.846153846 | |
3 | 5 | 29 | 150 | 29 | 417.24137931 | 5.172413793 | |
4 | 0 | 0 | |||||
5 | 0 | 0 | |||||
6 | 0 | 0 | |||||
7 | 0 | 0 | |||||
8 | 0 | 0 | |||||
9 | 0 | 0 | |||||
10 | 0 | 0 |
Describe the particle size distribution pattern and potential contamination source inference
Were active air sampling CFU tests conducted simultaneously?
Microbiological CFU Count Variance Analysis
Sampling Location | Culture Medium Used | Baseline CFU/m³ | Current CFU/m³ | Action Limit CFU/m³ | Incubation Period (hours) | Dominant Morphology Observed | ||
|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | G | ||
1 | At Rest (Center) | Tryptic Soy Agar | 1 | 15 | 5 | 48 | Coagulase-negative Staphylococcus | |
2 | In Operation (Fill Line) | Sabouraud Dextrose Agar | 3 | 45 | 10 | 120 | Aspergillus fumigatus | |
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
7 | ||||||||
8 | ||||||||
9 | ||||||||
10 |
Primary Contamination Type Classification
Inert Particulate Only (Non-viable)
Viable Microbial Contamination
Mixed Viable & Non-viable
Chemical Vapor/Aerosol
Pyrogenic/Endotoxin
Unknown - Requires Further Analysis
Probable Contamination Source Pathways (select all that apply)
HEPA Filter Bypass/Leak
Compromised Door Seal
Personnel Garment Breach
Material Transfer Hatch Malfunction
HVAC System Failure
Adjacent Construction Dust Intrusion
Cleaning Equipment Contamination
Water Intrusion/Moisture
Inadequate Decontamination Cycle
Other
Risk Assessment Matrix for Potential Contamination Sources
Very Low Risk | Low Risk | Moderate Risk | High Risk | Critical Risk | |
|---|---|---|---|---|---|
HEPA Filter Integrity | |||||
Air Handling Unit Performance | |||||
Room Pressurization Stability | |||||
Personnel Aseptic Technique Compliance | |||||
Material Transfer Protocol Adherence | |||||
Environmental Monitoring System Reliability |
Has the contaminant been identified to species level via biochemical or molecular methods?
Provide species identification, resistance profile, and clinical significance
Estimated Volume of Air Contaminated (cubic meters)
Are there any archived environmental monitoring data trends indicating gradual deterioration?
Describe the trend pattern and why preemptive action was not taken
This section addresses immediate operational cessation, patient safety protocols, and contingency relocation strategies to maintain clinical service continuity while ensuring absolute sterility assurance.
Has immediate quarantine and cessation of all sterile operations been enacted?
Exact Time of Quarantine Initiation
Justify why quarantine has not been implemented and provide risk mitigation strategy
Number of Scheduled Procedures/Compounding Activities Affected
Active and Pending Operations Impact Assessment
Procedure/Activity ID | Procedure Type | Patient/Order Identifier | Status at Detection | Contamination Risk Level | Disposal/Quarantine Actions Taken | ||
|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | ||
1 | OR-2025-0314-07 | Cardiac Bypass | PT-78451 | Anesthesia Induction Complete | Medium Risk - Intra-operative | All exposed instruments quarantined, case transferred to OR-8B | |
2 | CP-2025-0314-12 | TPN Compounding | RX-99234 | In Progress - Final Filtration | High Risk - Critical Exposure | Batch immediately discarded, full cleanroom decontamination initiated | |
3 | |||||||
4 | |||||||
5 | |||||||
6 | |||||||
7 | |||||||
8 | |||||||
9 | |||||||
10 |
Relocation Destination for Critical Operations
Backup Certified Cleanroom (Same Facility)
Alternative Surgical Suite (Same Facility)
Partner Institution Cleanroom
Emergency Mobile Cleanroom Unit
Operations Fully Cancelled Until Remediation
Not Applicable - No Active Operations
Has a Patient Safety Notification been issued for affected cases?
Summarize notification content and patient status monitoring plan
Detailed Relocation Protocol and Timeline
Communication Channels Activated (select all)
Facility Operations Command Center
Infection Prevention & Control Team
Clinical Department Heads
Risk Management Office
Regulatory Affairs
Biomedical Engineering
Facilities Management
External Certification Body
Patient Families (if applicable)
Other
Has a formal Incident Command System (ICS) been established?
Incident Commander Name & Role
Estimated Financial Impact of Operational Halt (in USD equivalent)
Overall Disruption Severity Rating (1=Minimal, 5=Catastrophic)
This section provides a systematic protocol for HEPA filtration system remediation, comprehensive surface and air decontamination, and recertification procedures to restore cleanroom to operational status.
Has the HVAC system been shut down to prevent cross-contamination?
Time of HVAC Shutdown
HEPA Filter Bank Integrity Assessment
Filter Location/ID | Last DOP/PAO Test Date | Last Penetration % | Visual Damage Observed | Scheduled for Replacement | Post-Test Integrity Status | ||
|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | ||
1 | HEPA-CR-7A-01 | 1/15/2025 | 0.005 | Yes | Filter integrity compromised - penetration 0.025% - REQUIRES IMMEDIATE REPLACEMENT | ||
2 | HEPA-CR-7A-02 | 1/15/2025 | 0.003 | Filter integrity acceptable - penetration 0.004% | |||
3 | |||||||
4 | |||||||
5 | |||||||
6 | |||||||
7 | |||||||
8 | |||||||
9 | |||||||
10 |
Decontamination Agents & Methods to be Employed (select all applicable)
Vaporized Hydrogen Peroxide (VHP) Bio-Decontamination
Formaldehyde Fumigation
Chlorine Dioxide Gas
Quaternary Ammonium Compound (QAC) Fogging
70% Isopropyl Alcohol (IPA) Wipe-Down
Sporicidal Disinfectant (e.g., bleach)
UV-C Germicidal Irradiation
Ozone Treatment
Other
Will a portable HEPA air scrubber/recirculation unit be deployed during remediation?
Unit Model & Certified Flow Rate (m³/h)
Detailed Stepwise Decontamination Protocol
Critical Equipment Decontamination Status
Equipment Name | Equipment ID | Requires Decontamination | Decon Method | Estimated Decon Duration (hours) | Post-Decon Validation Required | ||
|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | ||
1 | Biological Safety Cabinet | BSC-7A-03 | Yes | Disinfection | 2 | Yes | |
2 | Compounding Aseptic Isolator | CAI-7A-01 | Yes | Gas Plasma | 8 | Yes | |
3 | Environmental Monitor | EM-7A-05 | Not Required | 0 | |||
4 | |||||||
5 | |||||||
6 | |||||||
7 | |||||||
8 | |||||||
9 | |||||||
10 |
Will the decontamination process require third-party specialized contractor support?
Contractor Company Name & Certification
Projected Decontamination Completion Time
Effectiveness Assessment of Decontamination Methods (rate confidence level)
VHP Penetration in Dead Spaces | |
Surface Disinfection Coverage | |
Air Change Effectiveness | |
Filter Replacement Quality | |
Overall Protocol Confidence |
Has a post-decontamination environmental monitoring plan been established?
Describe sampling frequency, locations, and acceptance criteria for re-occupancy
Final authorization section requiring joint certification from microbiological and clinical leadership, confirming investigation completeness, risk mitigation adequacy, and clearance for resumption of sterile operations.
Executive Summary of Root Cause Analysis
Corrective and Preventive Actions (CAPA) Tracker
CAPA ID | Action Description | Priority | Responsible Department | Target Completion Date | Completed | ||
|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | ||
1 | CAPA-2025-0314-01 | Replace HEPA-CR-7A-01 filter bank and full DOP retest | Critical - Immediate | Facilities Engineering | 3/15/2025 | ||
2 | CAPA-2025-0314-02 | Implement enhanced differential pressure monitoring with SMS alerts | High - 24 hours | Biomedical Engineering | 3/16/2025 | ||
3 | CAPA-2025-0314-03 | Re-train pharmacy staff on material transfer protocols | Medium - 1 week | Quality Assurance | 3/21/2025 | ||
4 | |||||||
5 | |||||||
6 | |||||||
7 | |||||||
8 | |||||||
9 | |||||||
10 |
Have all post-remediation environmental tests met acceptance criteria?
Summarize final particle counts, CFU levels, and pressure differential readings
Describe ongoing remediation steps and revised timeline
Supporting Documentation Attached (select all)
Pre-Contamination Monitoring Logs
Real-Time Detection Data Export
Microbiological Culture Reports
HEPA Filter Integrity Test Results
Decontamination Cycle Records
Photographic Evidence
Personnel Training Certificates
Contractor Service Reports
Other
Has a risk assessment been conducted for resuming operations?
Provide risk level conclusion and any conditional operational restrictions
Lead Microbiologist Name & Professional Credentials
Lead Microbiologist Registration/License Number
Lead Microbiologist Digital Signature & Approval
Microbiologist Approval Timestamp
Chief of Clinical Operations Name & Title
Chief of Clinical Operations Registration/License Number
Chief of Clinical Operations Digital Signature & Approval
Clinical Operations Approval Timestamp
Is there any dissenting opinion or conditional approval from either signatory?
Document dissenting views, conditions, or requirements for enhanced monitoring
Additional Comments & Recommendations for Systemic Improvement
Has this incident been entered into the facility's adverse event tracking system?
To configure an element, select it on the form.